Panelists discuss how integrating metabolic, pharmacologic, and multidisciplinary strategies can bridge the obesity–MASH divide to improve early detection, treatment outcomes, and long-term public health impact.
EP. 1: Understanding the Metabolic–Hepatic Connection in MASH
Panelists discuss how metabolic dysfunction drives liver injury, highlighting early recognition of the obesity–MASH connection as key to prevention.
Watch
EP. 2: Enhancing Early Detection and Diagnosis in MASH
Panelists discuss how structured, multidisciplinary screening efforts can catch MASH earlier and prevent progression.
Watch